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X-linked inhibitor of apoptosis protein (XIAP) has
been identified as a potent regulator of innate im-
mune responses, and loss-of-function mutations
in XIAP cause the development of the X-linked lym-
phoproliferative syndrome type 2 (XLP-2) in humans.
Using gene-targeted mice, we show that loss of
XIAP or deletion of its RING domain lead to excessive
cell death and IL-1b secretion from dendritic cells
triggered by diverse Toll-like receptor stimuli. Aber-
rant IL-1b secretion is TNF dependent and requires
RIP3 but is independent of cIAP1/cIAP2. The
observed cell death also requires TNF and RIP3 but
proceeds independently of caspase-1/caspase-11
or caspase-8 function. Loss of XIAP results in aber-
rantly elevated ubiquitylation of RIP1 outside of
TNFR complex I. Virally infected Xiap/ mice pre-
sent with symptoms reminiscent of XLP-2. Our data
show that XIAP controls RIP3-dependent cell death
and IL-1b secretion in response to TNF, which might
contribute to hyperinflammation in patients with
XLP-2.
INTRODUCTION
X-linked inhibitor of apoptosis protein (XIAP) is an antiapoptotic
protein that inhibits induction of cell death in response to intrinsic
as well as extrinsic apoptotic stimuli (Gyrd-Hansen and Meier,
2010; Jost et al., 2009). Inhibition of apoptosis by XIAP is medi-
ated by inhibiting caspase-3 and caspase-7 via its N-terminal1796 Cell Reports 7, 1796–1808, June 26, 2014 ª2014 The Authorsbaculoviral IAP repeat (BIR) domains (Deveraux et al., 1997).
The first characterization of Xiap/ mice showed no obvious
phenotype (Olayioye et al., 2005), whereas recent studies have
demonstrated a reduced capacity of Xiap/ mice to clear
certain infectious pathogens (Bauler et al., 2008; Prakash et al.,
2010). In addition, the RING domain and the BIR2 domain of
XIAP have been implicated in nuclear factor-kB (NF-kB) and
mitogen-activated protein kinase (MAPK) signaling in response
to activation of nucleotide-binding oligomerization domain 1
(NOD1) and NOD2 (Damgaard et al., 2012, 2013).
To date, XIAP has not been implicated in tumor necrosis fac-
tor (TNF)/TNF receptor (TNFR) signaling despite a well-defined
role for its close IAP family members, cellular inhibitor of
apoptosis proteins 1 and 2 (cIAP1/cIAP2), in this pathway
(Gyrd-Hansen and Meier, 2010). cIAP1/cIAP2-dependent K63
ubiquitylation of receptor-interacting protein 1 (RIP1) after TNF
stimulation provides a prosurvival signaling platform allowing
for the induction of NF-kB and MAPK signaling (Bertrand
et al., 2008). Loss of cIAP1/cIAP2 or deubiquitylation of RIP1
coincides with the formation of secondary TNFR signaling
complexes (TNF-RSCs) that trigger cell death either through
caspase-8-mediated apoptosis or through RIP3- and MLKL-
dependent necroptosis (Murphy et al., 2013; O’Donnell et al.,
2011; Vince et al., 2007).
There are indications that elevated necroptosis contributes
to inflammation and tissue damage, at least in part, mediated
by interleukin-1b (IL-1b) (Gu¨nther et al., 2011; Kang et al.,
2013). IL-1b is an evolutionarily conserved cytokine that potently
mediates innate and adaptive immune responses, and its dereg-
ulation causes several autoinflammatory diseases (Lamkanfi
and Dixit, 2012). IL-1b is translated as an inactive proform and
requires processing into bioactive IL-1b by the inflammasome
(Martinon et al., 2002).
Mutations within BIRC4 (XIAP) have been identified as the
genetic cause of the X-linked lymphoproliferative syndrome
type 2 (XLP-2). The mutations mostly affect the C-terminal
RING domain or result in complete loss of protein expression
(Damgaard et al., 2013; Marsh et al., 2010; Pachlopnik Schmid
et al., 2011). Clinical symptoms aremostly attributed to the aber-
rant activation of macrophages and dendritic cells (DCs) and the
accumulation of activated T lymphocytes often in response
to viral infection (Marsh et al., 2010). This hyperactivation of im-
mune cells results in elevated systemic levels of proinflammatory
cytokines, such as IL-1b, interferon-g (IFNg), TNF, IL-6, and IL-
18 (Marsh et al., 2010; Rigaud et al., 2006; Wada et al., 2014).
We demonstrate here an unexpected function of XIAP in cur-
tailing excessive TNF-induced inflammasome activation. This
function was independent of cIAP1/cIAP2 and restricted IL-1b
production in a RIP3-dependent manner. Viral infection of
Xiap/ mice resulted in a hyperinflammatory phenotype similar
to that observed in patients with XLP-2, indicating that exagger-
ated IL-1b secretion might contribute to XLP-2 pathogenesis.
RESULTS
TLR Activation Induces Exaggerated IL-1b Secretion in
Xiap/ and XiapDRING Dendritic Cells
XLP-2 pathology in patients ismostly ascribed to a severe hyper-
inflammation in response to microbial infections. We therefore
hypothesized that microbial ligands trigger deregulated immune
responses in Xiap/ mice. To study cytokine responses, we
differentiated dendritic cslls (DCs) from bone marrow progeni-
tors (BMDCs) of mice lacking XIAP or expressing a knockin
allele of a RING-deleted version of XIAP termed XiapDRING
(Xiap DRING/DRING) (Olayioye et al., 2005; Schile et al., 2008) (Fig-
ure S1A). After treatment with ligands for Toll-like receptor 3
(TLR3), TLR4, and TLR9, we observed a significant increase of
IL-1b secretion from Xiap/ and XiapDRING BMDCs compared
to wild-type (WT) BMDCs. Whereas TNF secretion from Xiap/
and XiapDRING cells was comparable to WT, the exaggerated IL-
1b secretion correlated with increased cell death (Figure 1A). A
similar phenotype was also observed in bone marrow-derived
macrophages (BMDMs) (Figure S1B). IL-1b secretion and cell
death, measured by a decrease of intracellular ATP levels or
lactate dehydrogenase (LDH) release, occurred between 4 and
8 hr of lipopolysaccharide (LPS) exposure only in Xiap/
BMDCs (Figure 1B). However, NF-kB and MAPK signaling and
subsequent gene induction were largely identical in both geno-
types (Xiap/ and WT) in response to LPS, despite a minor
elevation of phosphorylated p38 in Xiap/ cells (Figures 1C
and S1C). The elevated secretion of IL-1b in Xiap/ BMDCs in
response to LPS was remarkable because conventional inflam-
masome activation requires a priming and an activating signal,
such as ATP, for inflammasome formation (Gross et al., 2012;
Martinon et al., 2002). The hypersecretion of IL-1b correlated
with the formation of conventional inflammasome complexes
as shown by accumulation of NOD-like receptor family pyrin
domain-containing 3 (NLRP3), Apoptosis-associated Speck-
like protein containing a CARD (ASC), and caspase-1 within
the NP-40-insoluble fraction only in Xiap/ cells, but not in WT
cells treated with LPS only (Figure 1D). WT BMDCs recruitedCASC and caspase-1 into the NP-40 fraction only after treatment
with LPS plus ATP (Figure 1D). We also observed recruitment of
caspase-8 into the NP-40 fraction in Xiap/ cells but not in WT
cells after LPS treatment (Figure 1D). Immunofluorescence
microscopy further confirmed ASC/caspase-1 speck formation
in Xiap/ BMDCs treated with LPS only (Figure 1E), whereas
speck formation inWT cells required the addition of ATP or niger-
icin (Gross et al., 2012) (Figures 1D and 1E).
Of note, conventional inflammasome activation in response to
ATP (Figure S1D) or nigericin (Figure 1E), and inflammasome in-
hibition by blocking potassium efflux or by caspase inhibition
(Figure S1E), was identical in WT and Xiap/ BMDCs. Together,
this demonstrated that the priming signal alone induced sub-
stantial inflammasome formation and IL-1b secretion in Xiap/
BMDCs, but not in WT BMDCs.
Because necrotic cell death can activate the inflammasome
(Lamkanfi and Dixit, 2012), we examined the connection be-
tween IL-1b secretion and cell death. To characterize the contri-
bution of damage-associated molecular pattern molecules
(DAMPs) released from dying cells to the IL-1b secretion
observed, we costimulated BMDCs with LPS plus lysates from
dead cells generated by repeated freeze-thaw cycles. This treat-
ment failed to further enhance IL-1b secretion after LPS (Fig-
ure S1F). In addition, we cocultured WT and Xiap/ BMDCs
prior to LPS stimulation. Supporting a DAMP-independent
cause of inflammasome activation, we observed caspase-1
specks only in Xiap/ cells, whereas directly adjacent WT cells
did not contain specks (Figure S1G). Our data argue that cell-
intrinsic signaling aberrations in Xiap/ and XiapDRING BMDCs
resulted in increased inflammasome formation.
Similar to the systemic cytokinemia observed in patients with
XLP-2, we hypothesized that activation of the innate immune
system might drive an exaggerated inflammatory response.
This was confirmed in amurine model of acute peritonitis elicited
by intraperitoneal (i.p.) injection of LPS or the adjuvant alum,
which both resulted in increased IL-1b levels in the peritoneal
fluid of Xiap/ mice when compared to WT (Figures 1F and
1G). These data show that TLR stimulation of DCs caused
elevated inflammasome formation and IL-1b secretion in vitro
and in vivo when XIAP was missing.
IL-1b Secretion in Response to LPS in Xiap/ BMDCs Is
Mediated by TNF Signaling
We next examined what factors control the IL-1b secretion in
Xiap/ cells. IL-1b secretion was reduced by caspase-1 inhibi-
tor treatment (YVAD), whereas an IL-1b receptor antagonist
(IL-1RA; anakinra) did not substantially reduce IL-1b levels in
Xiap/BMDCs, although some reduction was seen in XiapDRING
cells (Figure S2A). This argues against a prominent role for auto-
crine or paracrine IL-1 receptor signaling. In contrast, anti-TNF-a
(Enbrel) potently inhibited IL-1b secretion, reduced cell death,
and blocked processing of caspase-8 in Xiap/ and XiapDRING
BMDCs (Figures S2A and S2B).
In linewith a possible role of XIAP in regulating signaling events
downstream of TNF/TNFR, we observed elevated IL-1b secre-
tion and cell death in Xiap/ and XiapDRING BMDCs in response
to recombinant TNF (Figure 2A). This was interesting because
XIAP has not been directly implicated in TNF/TNFR signalell Reports 7, 1796–1808, June 26, 2014 ª2014 The Authors 1797
Figure 1. Exaggerated IL-1b Secretion in Xiap/ and XiapDRING BMDCs and Mice
(A) Secreted IL-1b, TNF, and survival of WT, Xiap/, and XiapDRING BMDCs treated with LPS, CpG (250 nM), polyI:C (10 mg/ml), or Muramyl dipeptide (MDP)
(10 mg/ml) for 24 hr. ctr, control; ns, not significant.
(legend continued on next page)
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transduction. Of note, we did not observe significant changes in
NF-kB orMAPK signaling and gene induction in response to TNF
in Xiap/ and XiapDRING BMDCs (Figures S2C and S2D).
To better define the role of XIAP in the control of TNF signaling,
we intercrossed Xiap/ mice with mice deficient for TNF
(Tnf tm1Gkl) (Pasparakis et al., 1996). BMDCs from Tnf/Xiap/
double-deficient mice differentiated normally in culture (Fig-
ure S2E). Supporting a critical role of TNF/TNFR signaling for
the observed phenotype, we found that genetic deletion of
TNF reduced IL-1b secretion to WT levels after LPS (Figure 2B).
Exogenous addition of recombinant TNF to Tnf
/
Xiap/
BMDCs fully recapitulated the excessive IL-1b production
observed in Xiap/ cells (Figure 2B). Deletion of TNF also
rescued Xiap/ BMDCs from cell death, implicating TNF-
induced signaling events in both inflammasome activation
and cell death (Figure 2B). Importantly, canonical inflamma-
some activation with ATP after a short priming stimulus with
LPS caused normal inflammasome activation in Tnf/ and
Tnf/Xiap/ BMDCs (Figure S2F). This is in agreement with
a previous report that showed that TNFR signaling was not
required for canonical IL-1bmaturation in response to a priming
and activating signal when all IAPs were antagonized (Vince
et al., 2012).
To understand the contribution of XIAP to IL-1b secretion and
lymphoproliferation in vivo, we analyzed mice immunized with
antigen-coated alum after 12 days. Alum induces a sustained in-
flammatory response primarily driven by NLRP3 inflammasome
activation in inflammatory CD11c+ DCs (Eisenbarth et al.,
2008; Kool et al., 2008). We observed an elevated splenic infiltra-
tion of inflammatory cells, such as neutrophils, macrophages,
and eosinophils, in Xiap/ mice when compared to WT mice
(Jordan et al., 2004) (Figure 2C), which is reminiscent of the
splenomegaly observed in many patients with XLP-2. In support
of a critical role for TNF/TNFR signaling, we observed that the
exaggerated splenic infiltration in Xiap/ mice was absent in
Tnf/Xiap/ mice (Figure 2C).
These data demonstrated that XIAP controls signaling events
downstream of TNF/TNFR and thereby protects from aberrant
inflammasome formation and cell death. The largely identical
phenotype observed in bothXiapDRING andXiap/BMDCs impli-
cated that XIAP functions as a ubiquitin ligase in this context.
Protection from Excessive Inflammasome Activation
and Cell Death Is Predominantly Mediated by XIAP
Cell death triggered by TNF is often a consequence of deregu-
lated ubiquitylation of RIP1 (Vandenabeele et al., 2010). cIAP1/
cIAP2 are ubiquitin ligases of RIP1 and have been shown to pro-
tect from aberrant IL-1b secretion after TLR4 activation (Vince
et al., 2012). To delineate the roles of cIAP1/cIAP2, from those(B) Secreted IL-1b, cell viability, and LDH release of WT and Xiap/ BMDCs tre
(C) Immunoblotting of cell lysates and culture media from WT and Xiap/ BMDC
(D) Immunoblotting of NP-40 insoluble fractions isolated from BMDCs after treatm
for 1 hr.
(E) Fluorescence microscopy of ASC/caspase-1 specks in WT and Xiap/ BMDC
and vimentin (red). Scale bars represent 20 mm.
(F and G) IL-1b from peritoneal fluid of WT and Xiap/ mice injected with (F) LP
Error bars represent mean ± SEM. Other data represent mean ± SEM of at least
Cof XIAP, we utilized the small molecule monovalent IAP antago-
nist (SMACmimetic) LCL161. This compound has a higher affin-
ity for cIAP1/cIAP2 than for XIAP and causes rapid degradation
only of cIAP1/cIAP2, but not of XIAP (Figure 2D) (Weisberg
et al., 2010).
cIAP1/cIAP2 depletion by LCL161 at 50 nM readily induced
IL-1b secretion and cell death only in Xiap/ cells, but not
in WT cells (Figure 2E). Upon stimulation with LPS, WT cells
depleted of cIAP1/cIAP2 failed to increase IL-1b secretion up
to doses of 500 nM LCL161 (Figure 2F). In contrast, depletion
of cIAP1/cIAP2 potently increased IL-1b secretion in Xiap/
cells (Figure 2F). Interestingly, the IL-1b production was mostly
TNF/TNFR dependent because Tnf/ and Tnf/Xiap/ cells
secreted significantly less IL-1b compared to WT and Xiap/
cells, respectively (Figure 2F). A TNF-independent contribution
to IL-1b secretion and cell death was observed only at LCL161
doses higher than 50 nM (Figure 2F).
To exclude the possibility that depletion of cIAP1 by LCL161 in
Xiap/ cells was not sufficient to deplete cIAP2 (Varfolomeev
et al., 2007), we probed for NF-kB-inducing kinase (NIK) stabili-
zation. We observed a similar elevation of NIK in both WT and
Xiap/ cells (Figures S2G and S2H), indicating that activation
of the noncanonical NF-kB pathway did not contribute to the
differential levels of IL-1b secretion and cell death.
In summary, depletion of cIAP1/cIAP2 was insufficient for IL-
1b secretion and cell death to occur when XIAP was present.
Depletion of cIAP1/cIAP2 only further promoted both outcomes
when XIAP was deleted. We conclude that protection from
excessive inflammasome activation and cell death in DCs after
TNFR or TLR4 activation is predominantly mediated by XIAP.
RIP3 Is Required for Cell Death and Inflammasome
Activation in Xiap/ BMDCs after TNF/TNFR or TLR4
Stimulation
RIP3 is a mediator of TNF-induced cell death and inflammation
(Murphy and Silke, 2014; Vandenabeele et al., 2010). We there-
fore determined the requirement for RIP3 for both outcomes
in XIAP-deficient cells by crossing Xiap/ mice with Rip3/
mice (Newton et al., 2004). Rip3/Xiap/ BMDCs differenti-
ated normally in culture (Figure S3A). After stimulation with
TNF (Figure 3A) or LPS (Figures S3B and S3C), the secretion
of processed IL-1b into the medium observed in Xiap/ cells
was completely abolished by loss of RIP3. The reduction in
IL-1b levels correlated with normal cell survival in response to
TNF or LPS, implying that inflammasome formation and cell
death signaling are both consequences of RIP3 activity (Figures
3A and S3C). Surprisingly, processing of caspase-8 into the
p17 subunit was absent in Rip3/Xiap/ BMDCs after TNF or
LPS treatment (Figures 3B and S3B). In addition, deletion ofated with LPS (5 ng/ml).
s treated with LPS (5 ng/ml).
ent with LPS (5 ng/ml) for 8 hr, or treatment with LPS for 2 hr plus ATP (5 mM)
s treated as indicated. Cells were stained for caspase-1 (yellow), nuclei (blue),
S (1 mg) or (G) alum crystals (700 mg) i.p. for 2 hr. n, number of mice.
three independent experiments performed in triplicates. See also Figure S1.
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Rip3 blocked inflammasome formation as measured by assem-
bly of ASC and caspase-1 within the NP-40 fraction (Figure 3C).
The critical role of RIP3 was also confirmed in vivo, where the
amount of IL-1b induced by LPS in Xiap/ mice was reduced
in Rip3/Xiap/ mice (Figure 3D). These findings identify
XIAP as a negative regulator of RIP3-dependent signaling in
response to TNF or LPS and detect a critical role for RIP3 in
the full activation of caspase-8 in this process.
XIAP Regulates Ubiquitylation of RIP1 outside the TNF-
RSC
The finding that XIAP restricted inflammasome activation and
cell death downstream of TNF/TNFR signaling prompted us to
investigate the impact of XIAP loss on the formation of the
TNF-RSC. We performed immunoprecipitations of the TNF-
RSC using FLAG-tagged TNF in WT or Xiap-/y HCT116 human
colorectal carcinoma cells, which have previously been shown
to fully form the TNF-RSC and propagate XIAP-dependent
signaling (Damgaard et al., 2012; Krieg et al., 2009). We
observed no differences in the composition or the ubiquitylation
of proteins within the TNF-RSC when XIAP was absent (Fig-
ure S3D). This is in line with our data that showed no significant
changes in NF-kB and MAPK activation, and gene induction,
in Xiap/ and XiapDRING BMDCs after TNF treatment (Figures
S2C and S2D).
We next tested whether XIAP alters RIP1 expression by prob-
ing for themRNA and protein levels of RIP1 in BMDCs. No signif-
icant changes were observed for RIP1 mRNA in response to
either LPS or TNF (Figure S3E). However, compared to WT
BMDCs, we observed elevated RIP1 protein levels in Xiap/
cells at baseline and after 8 hr of LPS treatment (Figure 3E).
The baseline elevation of RIP1 and the levels after stimulation
were dependent on TNF signaling because RIP1 levels were
lower in Tnf/Xiap/ cells (Figure 3E). The differences in pro-
tein levels despite normal mRNA expression suggest that XIAP
affects RIP1 in a posttranslational manner.
We therefore examined whether changes in the ubiquitylation
of RIP1 account for its increase. To pull down polyubiquitin
chains from BMDCs, we utilized tandem ubiquitin binding
entities (TUBEs) fused to glutathione S-transferase (GST).
Intriguingly, we found that RIP1 ubiquitylation was substantially
elevated after 30 and 60min of TNF treatment in Xiap/BMDCs
(Figure 3F). This finding was surprising because our data did not
show an increase of ubiquitin on RIP1 within the TNF-RSC (Fig-
ure S3D) and because depletion of cIAP1/cIAP2 by SMAC mi-
metics reduces RIP1 ubiquitylation (Bertrand et al., 2008). These
data therefore suggest that XIAP regulates RIP1 ubiquitylation
independently from cIAP1/cIAP2 and outside the TNF-RSC.Figure 2. XIAP Protects against Excessive IL-1b Secretion and Cell De
(A) IL-1b and cell survival of WT, Xiap/, and XiapDRING BMDCs treated with rec
(B) IL-1b and cell viability of WT, Xiap/, Tnf/, and Tnf/Xiap/ BMDCs afte
(C) Splenic lymphocytes, neutrophils, macrophages, and eosinophils fromWT (n =
coated alum crystals. Each dot represents a mouse, and error bars represent m
(D) Immunoblots of WT BMDCs treated with IAP antagonist LCL161 for 2 hr.
(E) IL-1b and cell survival of WT and Xiap/ BMDCs after LCL161 for 24 hr.
(F) IL-1b and cell viability of WT, Xiap/, Tnf/, and Tnf/Xiap/ BMDCs afte
Error bars represent mean ± SEM of at least three independent experiments per
CWe next investigated whether RIP3 contributes to the ubiquityla-
tion of RIP1, possibly in a RIP1-RIP3-containing protein complex
(Cho et al., 2009; Feoktistova et al., 2011; Tenev et al., 2011). We
found that genetic deletion of RIP3 completely blocked the aber-
rant RIP1 ubiquitylation observed in Xiap/ cells (Figure 3G).
Collectively, these data show that XIAP contributes to the regu-
lation of the ubiquitylation status of RIP1 in a RIP1-RIP3-contain-
ing complex outside of the TNF-RSC I.
Cell Death Is Induced Independently of Inflammasome
Activation in Xiap/ BMDCs
The critical role of RIP3 for the inflammasome activation and
cell death induction in Xiap/ cells prompted us to examine
the relationship between both outcomes. We therefore gener-
ated Caspase 1/11/Xiap/ mice (Kuida et al., 1995). In line
with previous literature, canonical inflammasome activation
induced by ATP was completely blocked in BMDCs from such
mice (Figures S4A and S4B).
After LPS treatment, we found a substantial reduction in IL-1b
levels in Caspase 1/11/Xiap/ mice compared to Xiap/
mice, implicating conventional inflammasome formation in this
process (Figures 4A–4C). Interestingly, IL-1b levels in Caspase
1/11/Xiap/ mice at 24 hr were still substantially elevated
compared to WT cells (Figure 4C). This suggested that process-
ing of pro-IL-1b by caspase-8 might cooperate with caspase-1
for IL-1b maturation. Indeed, Caspase 1/11/Xiap/ BMDCs
retained the elevated caspase-8 activity also observed in
Xiap/ cells (Figures 4A and 4B). Moreover, inhibition of cas-
pase-8 with the inhibitor Z-IETD-FMK (IETD) further reduced
IL-1b levels at 8 and 24 hr (Figures 4B and 4C), implying that cas-
pase-8 contributes to IL-1b maturation in Xiap/ BMDCs. We
therefore tested the recruitment of both caspases into the NP-
40 fraction in response to LPS. We observed that LPS treatment
was sufficient to cause recruitment of caspase-8 and caspase-1
into this fraction in Xiap/ cells, whereas WT cells required ca-
nonical inflammasome activation with ATP for this to occur (Fig-
ures 1D, 3C, and 4D). Of note, recruitment of caspase-8 to the
NP-40 fraction was unperturbed in mice lacking caspase-1/cas-
pase-11 (Figure 4D). In addition, inhibition of caspase-8 with
IETD did not prevent caspase-1 recruitment to the NP-40 frac-
tion in Xiap/ cells (Figure 4E). Collectively, these data show
that recruitment and activation of caspase-1 and caspase-8
occur independently of each other but that both cooperate in
the processing of pro-IL-1b.
Importantly, we observed no effect of deletion of caspase-1/
caspase-11 on the cell death of Xiap/ cells (Figures 4B and
4C). Additional inhibition of caspase-8 (Figures 4B and 4C) and
complete inhibition of all caspase activity using the caspaseath in a TNF-Dependent Manner
ombinant TNF (recTNF) at 10, 50, and 100 ng/ml.
r LPS (5 ng/ml) with or without recTNF (100 ng/ml).
8),Xiap/ (n = 7), and Tnf/Xiap/ (n = 5) mice 12 days after injection i.p. with
ean ± SEM.
r LPS and LCL161 at 1, 5, 10, 50, 100, 200, and 500 nM for 24 hr.
formed in triplicates. See also Figure S2.
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inhibitor ZVAD also failed to rescue the viability of Xiap/ cells
(Figure S4C). Whereas the precise function of caspase-8 in
this context remains unresolved, our data clearly showed that
cell death induction was nonapoptotic and independent from
inflammasome activation.
Loss of XIAP Drives Excessive Inflammation in a Murine
Model of EBV Mononucleosis
XLP-2 pathology in patients is often triggered by an Epstein-Barr
virus (EBV) infection. As a murine model for EBV mononucleosis,
we studied the immune response of Xiap/ mice to murine
g-herpesvirus 68 (MHV-68) (Barton et al., 2011). In this model,
intranasal (i.n.) infection with MHV-68 results in a productive
infection of the respiratory tract (Stevenson and Efstathiou,
2005) that is followed by the transfer of the infection to lymphoid
tissues. Latent infection is established in the spleen within
2–3 weeks postinfection (p.i.), after which the number of latently
infected splenocytes returns to basal levels (Barton et al., 2011)
(Figure 5A).
Despite normal viral clearance during early infection (days 6
and 16) (Figure 5B; data not shown), we found increased viral
genomic loads in the spleens of infected Xiap/ mice during
late (day 43) and very late (day 84) latency (Figure 5B). On
day 16, the cellularity of Xiap/ and XiapDRING spleens was
increased compared to those of WT mice, which was reflected
by the increased numbers of myeloid and lymphoid populations
in the spleen (Figure 5C). Because CD4+ T lymphocytes are
important for the regulation of the viral loads of MHV-68, we
measured T cell populations during active infection and early
latency (Figure 5D). Despite equivalent values on day 6 p.i.,
the levels of CD4+ effector T cells, regulatory T cells (Treg),
and IFNg+ T cells were substantially elevated in Xiap/ and
XiapDRING mice at day 16 p.i., a phenotype also observed in
patients with XLP-2 (Figure 5D).
In line with our in vitro data, we found substantially elevated
IL-1b levels in the peripheral blood of Xiap/ mice at day 16
p.i., whereas TNF was comparable between both genotypes
(Figure 5E). Together, this shows that g-herpesvirus infection
drives hyperinflammation in Xiap/ mice, similar to what is
seen in EBV-infected patients with XLP-2.
Based on our findings showing the TNF-dependent nature of
the excessive IL-1b secretion in Xiap/ BMDCs and mice, we
hypothesized that deletion of TNF would ameliorate some of
the phenotypes observed. Indeed, during early infection at
day 6 p.i., Tnf/Xiap/ mice failed to induce IL-1b induction,
whereas at day 16 p.i., stimuli other than TNF induced IL-1bFigure 3. TNF Induces Elevated Ubiquitylation of RIP1 and Drives RIP3-
(A) IL-1b secretion and survival of WT, Xiap/, and Rip3/Xiap/ BMDCs t
independent experiments performed in triplicates.
(B) Immunoblots of WT, Xiap/, and Rip3/Xiap/ BMDCs treated with TNF (
(C) Immunoblots of NP-40 insoluble fractions of WT, Xiap/, and Rip3/Xiap/
(5 mM) for 1 hr.
(D) Cytokines from peritoneal fluid of WT (n = 4), Xiap/ (n = 4), andRip3/Xiap/
Error bars represent mean ± SEM.
(E) Immunoblots of extracts from WT, Xiap/, Tnf/, and Tnf/Xiap/ BMDC
(F) Immunoblots of GST-TUBE ubiquitin pull-down from WT and Xiap/ BMDCs
(G) Immunoblots of GST-TUBE ubiquitin pull-down from WT, Xiap/, and Rip3
See also Figure S3.
Cproduction comparable to the levels observed in Xiap/ mice
(Figure 5E). Consistently, we observed a reduction in myeloid
and lymphoid subpopulations infiltrating the spleen in
Tnf/Xiap/ mice at day 16 p.i. (Figures 5F and 5G). Finally,
in agreement with our previous data, deletion of RIP3 also
reduced the cellular infiltrations observed in spleens of Xiap/
mice after viral infection (Figure S5A), further supporting a role
for RIP3-dependent cell death and inflammation observed in
Xiap/ mice.
In summary, the phenotype observed in Xiap/ and XiapDRING
mice mimicked XLP-2 pathology, which is characterized by the
effort of the immune system to clear an infectious pathogen,
such as EBV, causing severe hyperinflammation. Importantly,
genetic deletion of TNF ameliorated the symptoms, supporting
the causative nature of TNF in this process and indicating a
potential therapeutic benefit of TNF inhibition for patients with
XLP-2 during early infection.
DISCUSSION
Excessive RIP3-dependent cell death has been shown to cause
elevated cytokine production and inflammation collectively re-
sulting in severe tissue damage (Murphy and Silke, 2014). This
is exemplified, for example, by the development of severe termi-
nal ileitis in Crohn’s disease due to necroptosis of Paneth cells
(Gu¨nther et al., 2011). Necroptosis-inhibiting proteins are there-
fore critical regulators of tissue homeostasis (Gu¨nther et al.,
2011; Kang et al., 2013; Welz et al., 2011). Our data identify
XIAP as an inhibitor of RIP3-dependent cell death and inflamma-
tion and show that loss of XIAP expression in mice causes
hyperinflammation that mimics human XLP-2 pathology (Marsh
et al., 2010).
Unexpectedly, our data place XIAP downstream of TNF
signaling, despite the fact that it is not directly involved in the for-
mation of the TNF-RSC I. The role of XIAP in TNFR signaling has
mainly been characterized in mouse embryonic fibroblasts
(MEFs). Contrary to cIAP1, XIAP is not involved in propagating
canonical NF-kB activation in response to TNF in MEFs (Moulin
et al., 2012) and fails to increase retention of RIP1 within the TNF
signaling complex I (Vince et al., 2007). In contrast, our data
place XIAP’s function outside of the TNF-RSC I, where it controls
the cellular fate of DCs by regulating RIP1 ubiquitylation together
with RIP3 within a TNF/TNFR-induced signaling complex IIb
(also termed ripoptosome or necrosome) (Murphy and Silke,
2014; Tenev et al., 2011). Whether XIAP directly interacts with
RIP1 and/or RIP3 or whether the aberrant ubiquitylation ofDependent Inflammasome Formation and Cell Death in Xiap/Mice
reated with TNF (100 ng/ml). Data represent mean ± SEM of at least three
100 ng/ml).
BMDCs after LPS (5 ng/ml) for 8 hr, or LPS (10 ng/ml) primed for 2 hr plus ATP
 (n = 5) mice after 2 hr of LPS (1 mg) i.p. Each data point represents onemouse.
s after treatment with LPS (5 ng/ml).
treated with TNF (100 ng/ml).
/ Xiap/ BMDCs treated with TNF (100 ng/ml).
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Figure 4. Caspase-1/Caspase-11 and Partially Caspase-8 Drive IL-1b Processing in Xiap/ Mice, but Both Are Dispensable for Cell Death
(A) Immunoblots of cell extracts and media from WT, Xiap/, and Caspase 1/11/Xiap/ BMDCs treated with LPS (5 ng/ml).
(B and C) Relative caspase-8 activity, IL-1b secretion, and survival of WT, Xiap/, and Caspase 1/11/Xiap/ BMDCs after LPS (5 ng/ml) with or without the
caspase-8 inhibitor IETD-fmk (IETD) (10 mM) for (B) 8 hr or (C) 24 hr.
(D) NP-40 insoluble fractions of WT, Xiap/, and Caspase 1/11/Xiap/ BMDCs after LPS (5 ng/ml) for 8 hr, or LPS for 2 hr (10 ng/ml) plus ATP (5 mM) for 1 hr.
(E) NP-40 fractions of WT and Xiap/ BMDCs with LPS (5 ng/ml) for 8 hr with or without IETD.
Error bars represent mean ± SEM of at least three independent experiments performed in triplicates. See also Figure S4.
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RIP1 favors binding to RIP3 remains unresolved, and these
questions will be important to further investigate in the future.
The ubiquitylation status of RIP1 is a key factor that influences
the switch between cell survival, apoptosis and RIP3-dependent
cell death downstream of the TNFR. RIP1 has been shown to be
decorated with M1, K11-, K48-, and K63-linked ubiquitin chains
(Bertrand et al., 2011; Gerlach et al., 2011; Haas et al., 2009).
cIAP1/cIAP2 have been implicated as mediators of the K48 and
K63 linkages (Bertrand et al., 2011). Loss of these K48/K63 link-
ages, either via the action of specific deubiquitinases (DUBs) or
by IAP antagonists, leads to cell death (Feoktistova et al., 2011;
O’Donnell et al., 2011), whereas loss of the linear M1 linkage
attenuates the NK-kB transcriptional response also resulting in
elevated cell death (Gerlach et al., 2011; Haas et al., 2009; Ikeda
et al., 2011). XiapDRING mutant mice, which express a truncated
XIAP missing only the ligase function, presented with an almost
identical phenotype compared to Xiap/ mice. This supports
the notion that XIAP functions as a ubiquitin ligase in TNFR/TNF
signaling and that coordinated ubiquitylation events downstream
of TNFR are tightly controlled by IAPs, including XIAP.
We observed an aberrant and prolonged ubiquitylation of RIP1
after TNF stimulation in cells lacking XIAP. Our data argue that
XIAP functions as a ubiquitin ligase controlling the ubiquitylation
of RIP1 either directly or indirectly, e.g., by affecting another
ubiquitin ligase or DUB, which is important for ensuring correct
RIP1 ubiquitylation. Indeed, there is emerging evidence that
RIP1 ubiquitylation is tightly balanced by multiple ubiquitin li-
gases and DUBs and that altering this balance results in aberrant
signaling and cell death (Gerlach et al., 2011; Keusekotten et al.,
2013; O’Donnell et al., 2011; Wertz et al., 2004).
We show that XIAP cooperates with cIAP1/cIAP2 in diverging
TNFR/TNF signaling away from cell death. However, XIAP clearly
functions independently of cIAP1/cIAP2. This is exemplified
by the fact that deletion of XIAP alone is sufficient to drive the
observed phenotype and by the observation that deletion of
XIAP causes aberrantly elevated ubiquitylation of RIP1 instead
of the reduced RIP1 ubiquitylation observed when cIAP1/
cIAP2 are inhibited (Bertrand et al., 2008)
XLP-2 is currently considered a familial hemophagocytic
lymphohistiocytosis (HLH) disease despite the lack of the char-
acteristic defects of CD8+ T cell and natural killer cell cytotoxicity
usually present in familial patients with HLH (Marsh et al., 2010).
The protection of DCs and macrophages against RIP3-depen-
dent cell death and inflammation afforded by XIAP argues that
loss-of-function mutations constitute a major underlying cause
of XLP-2 pathology. TNF was identified as the prime causative
cytokine in our study, and genetic inhibition ameliorated someFigure 5. Xiap/ and XiapDRING Mice Infected with MHV-68 Develop E
(A) Schematic overview of the MHV-68 infection model.
(B) MHV-68 viral genomic load of spleens from infected WT and Xiap/ mice de
(C) Flow cytometric analyses of spleens of infected WT, Xiap/, and XiapDRING m
(D) T cell subsets of infected mice were analyzed as in (C). Effector T cells were d
FOXP3+.
(E) IL-1b and TNF from sera of infected WT, Xiap/, and Tnf/Xiap/ mice at
(F) Flow cytometric analysis of spleens of infected Xiap/ and Tnf/Xiap/ mi
(G) T cell numbers from mice in (F).
Each dot represents a mouse, and error bars represent mean ± SEM. See also F
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alternative inflammatory pathways, such as IFN signaling, we
suggest that patients with XLP-2 might profit from therapeutic
TNF inhibition when used early during an inflammatory episode
(Mischler et al., 2007).
EXPERIMENTAL PROCEDURES
Mice
Xiap/ (Olayioye et al., 2005) and XiapDRING (Schile et al., 2008) mice have
been previously described. Tnf tm1Gkl (Tnf/) (Pasparakis et al., 1996) and
Casp1tm1Flv/J (Caspase-1/Caspase-11/) (Kuida et al., 1995) mice were pur-
chased from Jackson Laboratories. Rip3/ mice were obtained under a ma-
terial transfer agreement fromGenentech and have been previously described
by Newton et al. (2004). Both male and female mice deficient for BIRC4 were
denoted Xiap/. All animal experiments were performed in compliance with
protocols approved by the local animal ethics committee guidelines.
Inflammasome Formation in BMDCs
To monitor inflammasome formation by fluorescence microscopy, cells
treated with or without nigericin (5 mM) (Sigma-Aldrich) for 20–30 min after
LPS priming for 2 hr were seeded on chamber slides and probed with anti-
bodies against caspase-1 (Casper-2 clone; Adipogen) and vimentin (D21H3;
Cell Signaling Technology). Images were acquired with a Leica DMRBE
fluorescence microscope. For inflammasome-enrichment studies, cells were
treated with LPS or TNF for the indicated times, and the insoluble fraction of
the NP-40-lysed cells was collected by centrifugation and analyzed by SDS-
PAGE and immunoblotting for ASC, caspase-1 (Casper-1 clone), as previously
described (Gross et al., 2012).
Alum-Induced Peritonitis and Immunization
Eight to 12-week-old age- and sex-matched mice were injected i.p. with
700 mg Imject Alum Adjuvant (Thermo Scientific) in 200 ml PBS. Peritoneal fluid
was collected 2 hr postinjection and concentrated to 100 ml with 10 kDa
MWCO Vivaspin filters (Vivascience), and cytokines were measured by Cyto-
kine Bead Array (BD Biosciences). For immunization, ovalbumin (100 mg)
(Sigma-Aldrich; A2512) and LPS (10 mg) (Sigma-Aldrich; L2880) were precipi-
tated with alum (4.4 mg) (Roth P724.1). Each mouse was injected with the
precipitate that was washed once with PBS. Spleens of mice were analyzed
by flow cytometry 12 days later.
Intranasal MHV-68 Infection
Intranasal (i.n) infection of mice was performed as previously described by
El-Gogo et al. (2007) and Stevenson and Efstathiou (2005). In brief, mice
were infected i.n. with 53 104 plaque-forming units. Lytic virus titers of infected
lungs were determined on day 6, and splenic latent viral load was performed
by real-time PCR. At days 6 and 16 p.i., spleens of infectedmicewere analyzed
by flow cytometry analysis, and cytokines were measured from blood sera.
Statistical Analyses
The Wilcoxon-Mann-Whitney test was used to compare levels of serum cyto-
kines and differences in cellular populations. All values are expressed as the
mean ± SEM, and p < 0.05 (*), p < 0.005 (**), and p < 0.0005 (***) werexcessive Inflammation
termined on days 16, 43, and 84 p.i.
ice were analyzed at days 6 and 16 p.i.
efined as TCRb+, CD4+, CD44high, CD62Llow, and T-regs as CD4+, CD25+, and
days 6 and 16 p.i.
ce at days 6 and 16 p.i.
igure S5.
considered statistically significant. Statistical analyses and graphing were per-
formed with GraphPad Prism software.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.05.008.
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